2021 ASCO Virtual Annual Meeting*

Download All
June 4-8, 2021; Online at https://conferences.asco.org/am
Review slidesets and expert analyses of key data from the 2021 Clinical Oncology Virtual Scientific Meeting!
person default
Angeles Alvarez Secord, MD
Michael A. Davies, MD, PhD
Ian W. Flinn, MD, PhD
Shaji K. Kumar, MD
Evan J. Lipson, MD
Joyce O'Shaughnessy, MD
Daniel P. Petrylak, MD
Zofia Piotrowska, MD, MHS
Elizabeth R. Plimack, MD, MS
Karen L. Reckamp, MD, MS
Manish A. Shah, MD
Eunice S. Wang, MD

An Expert’s Guide to ASCO 2021: A Preview of the Top Abstracts

Experts highlight key studies being presented at the upcoming 2021 ASCO virtual meeting. The CCO ASCO Virtual Conference Coverage program will have the information you need to understand and integrate the latest oncology data into your practice.

person default Angeles Alvarez Secord, MD Michael A. Davies, MD, PhD Ian W. Flinn, MD, PhD Shaji K. Kumar, MD Evan J. Lipson, MD Joyce O'Shaughnessy, MD Daniel P. Petrylak, MD Zofia Piotrowska, MD, MHS Elizabeth R. Plimack, MD, MS Karen L. Reckamp, MD, MS Manish A. Shah, MD Eunice S. Wang, MD Released: June 2, 2021

Breast Cancer and Gynecologic Cancers

Hematologic Malignancies

Lung Cancer

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
AbbVie
Amgen
AstraZeneca
Bristol-Myers Squibb
Daiichi Sankyo, Inc.
Exelixis
Gilead Sciences, Inc.
GlaxoSmithKline
Ipsen Biopharmaceuticals, Inc.
Merck Sharp & Dohme Corp.
Novartis Pharmaceuticals Corporation
Pfizer, Inc.
Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.
Sanofi Genzyme

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue